Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
835M
-
Number of holders
-
228
-
Total 13F shares, excl. options
-
23.6M
-
Shares change
-
+49.7K
-
Total reported value, excl. options
-
$1.73B
-
Value change
-
+$4.04M
-
Put/Call ratio
-
0.34
-
Number of buys
-
118
-
Number of sells
-
-91
-
Price
-
$73.35
Significant Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q1 2024
255 filings reported holding RDY - DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share as of Q1 2024.
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) has 228 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23.6M shares
of 835M outstanding shares and own 2.83% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.18M shares), Royal Bank of Canada (2.16M shares), Robeco Institutional Asset Management B.V. (1.97M shares), RENAISSANCE TECHNOLOGIES LLC (1.93M shares), GOLDMAN SACHS GROUP INC (1.56M shares), Aikya Investment Management Ltd (1.24M shares), VANGUARD GROUP INC (1.02M shares), BANK OF AMERICA CORP /DE/ (892K shares), DIMENSIONAL FUND ADVISORS LP (889K shares), and MORGAN STANLEY (877K shares).
This table shows the top 228 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.